122 related articles for article (PubMed ID: 38554302)
21. Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli.
Bacci G; Ferrari S; Bertoni F; Rimondini S; Longhi A; Bacchini P; Forni C; Manfrini M; Donati D; Picci P
J Clin Oncol; 2000 Jan; 18(1):4-11. PubMed ID: 10623687
[TBL] [Abstract][Full Text] [Related]
22. Radiotherapy in Ewing's sarcoma and PNET of the chest wall: results of the trials CESS 81, CESS 86 and EICESS 92.
Schuck A; Hofmann J; Rübe C; Hillmann A; Ahrens S; Paulussen M; Jürgens H; Dunst J; Willich N
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1001-6. PubMed ID: 9869222
[TBL] [Abstract][Full Text] [Related]
23. Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: outcome and prognostic factors.
Krasin MJ; Rodriguez-Galindo C; Billups CA; Davidoff AM; Neel MD; Merchant TE; Kun LE
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):830-8. PubMed ID: 15465200
[TBL] [Abstract][Full Text] [Related]
24. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
Miser JS; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Grier HE
J Clin Oncol; 2004 Jul; 22(14):2873-6. PubMed ID: 15254055
[TBL] [Abstract][Full Text] [Related]
25. Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol.
Ferrari S; Sundby Hall K; Luksch R; Tienghi A; Wiebe T; Fagioli F; Alvegard TA; Brach Del Prever A; Tamburini A; Alberghini M; Gandola L; Mercuri M; Capanna R; Mapelli S; Prete A; Carli M; Picci P; Barbieri E; Bacci G; Smeland S
Ann Oncol; 2011 May; 22(5):1221-1227. PubMed ID: 21059639
[TBL] [Abstract][Full Text] [Related]
26. Localized Adult Ewing Sarcoma: Favorable Outcomes with Alternating Vincristine, Doxorubicin, Cyclophosphamide, and Ifosfamide, Etoposide (VDC/IE)-Based Multimodality Therapy.
Pretz JL; Barysauskas CM; George S; Hornick JL; Raut CP; Chen YE; Marcus KJ; Choy E; Hornicek F; Ready JE; DeLaney TF; Baldini EH
Oncologist; 2017 Oct; 22(10):1265-1270. PubMed ID: 28550026
[TBL] [Abstract][Full Text] [Related]
27. Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial.
Le Deley MC; Paulussen M; Lewis I; Brennan B; Ranft A; Whelan J; Le Teuff G; Michon J; Ladenstein R; Marec-Bérard P; van den Berg H; Hjorth L; Wheatley K; Judson I; Juergens H; Craft A; Oberlin O; Dirksen U
J Clin Oncol; 2014 Aug; 32(23):2440-8. PubMed ID: 24982464
[TBL] [Abstract][Full Text] [Related]
28. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.
Navid F; Santana VM; Billups CA; Merchant TE; Furman WL; Spunt SL; Cain AM; Rao BN; Hale GA; Pappo AS
Cancer; 2006 Apr; 106(8):1846-56. PubMed ID: 16541446
[TBL] [Abstract][Full Text] [Related]
29. Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group.
Yock TI; Krailo M; Fryer CJ; Donaldson SS; Miser JS; Chen Z; Bernstein M; Laurie F; Gebhardt MC; Grier HE; Tarbell NJ;
J Clin Oncol; 2006 Aug; 24(24):3838-43. PubMed ID: 16921035
[TBL] [Abstract][Full Text] [Related]
30. Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study.
Craft A; Cotterill S; Malcolm A; Spooner D; Grimer R; Souhami R; Imeson J; Lewis I
J Clin Oncol; 1998 Nov; 16(11):3628-33. PubMed ID: 9817284
[TBL] [Abstract][Full Text] [Related]
31. Ewing's sarcoma: experience with 12 cases.
Zülfikar B; Gedikoğlu G
J Chemother; 1992 Feb; 4(1):50-5. PubMed ID: 1403071
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors and clinical outcome of patients with Ewing's sarcoma family of tumors in adults: multicentric study of the Anatolian Society of Medical Oncology.
Arpaci E; Yetisyigit T; Seker M; Uncu D; Uyeturk U; Oksuzoglu B; Demirci U; Coskun U; Kucukoner M; Isıkdogan A; Inanc M; Alkis N; Ozkan M
Med Oncol; 2013 Mar; 30(1):469. PubMed ID: 23345116
[TBL] [Abstract][Full Text] [Related]
33. [Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patients treated with a 6-drug chemotherapeutic protocol (vincristine, adriamycin, cyclophosphamide, dactinomycin, ifosfamide and etoposide)].
Bacci G; Ferrari S; Rosito P; Barbieri E; Mercuri M; Brach del Prever A; Iantorno D; Forni C; Campanacci M
Minerva Pediatr; 1995 Nov; 47(11):457-69. PubMed ID: 8684341
[TBL] [Abstract][Full Text] [Related]
34. Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol.
Elomaa I; Blomqvist CP; Saeter G; Akerman M; Stenwig E; Wiebe T; Björk O; Alvegård TA
Eur J Cancer; 2000 May; 36(7):875-80. PubMed ID: 10785592
[TBL] [Abstract][Full Text] [Related]
35. Ewing's sarcoma and primitive neuroectodermal tumour in adults: single-centre experience in The Netherlands.
Smorenburg CH; van Groeningen CJ; Meijer OW; Visser M; Boven E
Neth J Med; 2007 Apr; 65(4):132-6. PubMed ID: 17452761
[TBL] [Abstract][Full Text] [Related]
36. Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86.
Paulussen M; Ahrens S; Dunst J; Winkelmann W; Exner GU; Kotz R; Amann G; Dockhorn-Dworniczak B; Harms D; Müller-Weihrich S; Welte K; Kornhuber B; Janka-Schaub G; Göbel U; Treuner J; Voûte PA; Zoubek A; Gadner H; Jürgens H
J Clin Oncol; 2001 Mar; 19(6):1818-29. PubMed ID: 11251014
[TBL] [Abstract][Full Text] [Related]
37. Outcome analysis of patients with transformed teratoma to primitive neuroectodermal tumor.
Ehrlich Y; Beck SDW; Ulbright TM; Cheng L; Brames MJ; Andreoiu M; Foster RS; Einhorn LH
Ann Oncol; 2010 Sep; 21(9):1846-1850. PubMed ID: 20231305
[TBL] [Abstract][Full Text] [Related]
38. Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial.
Brennan B; Kirton L; Marec-Bérard P; Gaspar N; Laurence V; Martín-Broto J; Sastre A; Gelderblom H; Owens C; Fenwick N; Strauss S; Moroz V; Whelan J; Wheatley K
Lancet; 2022 Oct; 400(10362):1513-1521. PubMed ID: 36522207
[TBL] [Abstract][Full Text] [Related]
39. Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone.
Meyer WH; Kun L; Marina N; Roberson P; Parham D; Rao B; Fletcher B; Pratt CB
J Clin Oncol; 1992 Nov; 10(11):1737-42. PubMed ID: 1403056
[TBL] [Abstract][Full Text] [Related]
40. Long-term results in 144 localized Ewing's sarcoma patients treated with combined therapy.
Bacci G; Toni A; Avella M; Manfrini M; Sudanese A; Ciaroni D; Boriani S; Emiliani E; Campanacci M
Cancer; 1989 Apr; 63(8):1477-86. PubMed ID: 2924256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
